# SD Cystic Fibrosis Study

> **NCT00605761** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 9 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** SB656933
- **DRUG:** SB656933

## Key facts

- **NCT ID:** NCT00605761
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2012-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605761, "SD Cystic Fibrosis Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00605761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*